Hyo Jung Kim

5PUBLICATIONS
13CO-AUTHORS
ChemotherapyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 01, 2025
The FOXP1-ABCG2 axis promotes the proliferation of cancer stem cells and induces chemoresistance in pancreatic cancer.

Woosol Chris Hong, Minsoo Kim, Ju Hyun Kim

|Mar 07, 2025
SLC5A3 depletion promotes apoptosis by inducing mitochondrial dysfunction and mitophagy in gemcitabine-resistant pancreatic cancer cells.

Minsoo Kim, Woosol Chris Hong, Hyeon Woong Kang

|Nov 02, 2023
Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc signaling pathway by inducing β-catenin ubiquitination in pancreatic cancer.

Hyeon Woong Kang, Ju Hyun Kim, Da Eun Lee

|Oct 27, 2023
SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic Cancer.

Myeong Jin Kim, Hyung Sun Kim, Hyeon Woong Kang

|Sep 22, 2023
The role of LOXL2 induced by glucose metabolism-activated NF-κB in maintaining drug resistance through EMT and cancer stemness in gemcitabine-resistant PDAC.

Yun Sun Lee, Hyung Sun Kim, Hyo Jung Kim

Pageof 1

Frequent Collaborators

3 joint publications

Hyeon Woong Kang

2 joint publications

Joon Seong Park

2 joint publications

SungSoon Fang

2 joint publications

Minsoo Kim